BIO-TECHNE Corp Comprehensive Income
BIO-TECHNE Corp (TECH) reported Comprehensive Income of $171.16 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-24
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $50.90M, a 1032.55% increase year-over-year.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $46.53M, a 77.71% increase year-over-year.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $40.06M, a 329.51% increase year-over-year.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $33.67M, a 35.04% decline year-over-year.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was $171.16M, a 86.38% increase from fiscal 2025.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $91.84M, a 41.08% decline from fiscal 2024.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $155.85M, a 47.06% decline from fiscal 2023.
- BIO-TECHNE Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $294.40M, a 15.84% increase from fiscal 2022.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $97.43M derived: sum of 2 quarters · filed 2026-08-24 | $137.49M derived: sum of 3 quarters · filed 2026-08-24 | $171.16M 10-K · filed 2026-08-24 | |||
| 2026-03-31 | $46.53M 10-Q · filed 2026-05-06 | $86.59M derived: sum of 2 quarters · filed 2026-05-06 | $120.27M 10-Q · filed 2026-05-06 | $124.76M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-12-31 | $40.06M 10-Q · filed 2026-02-04 | $73.73M 10-Q · filed 2026-02-04 | $78.22M derived: sum of 3 quarters · filed 2026-08-24 | $104.41M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-09-30 | $33.67M 10-Q · filed 2025-11-05 | $38.16M derived: sum of 2 quarters · filed 2026-08-24 | $64.35M derived: sum of 3 quarters · filed 2026-08-24 | $73.68M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-06-30 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $30.68M derived: sum of 2 quarters · filed 2026-08-24 | $40.01M derived: sum of 3 quarters · filed 2026-08-24 | $91.84M 10-K · filed 2026-08-24 | |||
| 2025-03-31 | $26.19M 10-Q · filed 2026-05-06 | $35.51M derived: sum of 2 quarters · filed 2026-05-06 | $87.34M 10-Q · filed 2026-05-06 | $124.92M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-12-31 | $9.33M 10-Q · filed 2026-02-04 | $61.16M 10-Q · filed 2026-02-04 | $98.73M derived: sum of 3 quarters · filed 2026-08-24 | $136.15M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-09-30 | $51.83M 10-Q · filed 2025-11-05 | $89.41M derived: sum of 2 quarters · filed 2026-08-24 | $126.82M derived: sum of 3 quarters · filed 2026-08-24 | $168.64M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | $37.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $74.99M derived: sum of 2 quarters · filed 2026-08-24 | $116.81M derived: sum of 3 quarters · filed 2026-08-24 | $155.85M 10-K · filed 2026-08-24 | |||
| 2024-03-31 | $37.41M 10-Q · filed 2025-05-08 | $79.23M derived: sum of 2 quarters · filed 2025-05-08 | $118.27M 10-Q · filed 2025-05-08 | $201.25M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | $41.82M 10-Q · filed 2025-02-06 | $80.86M 10-Q · filed 2025-02-06 | $163.83M derived: sum of 3 quarters · filed 2025-08-22 | $235.62M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | $39.04M 10-Q · filed 2024-11-05 | $122.01M derived: sum of 2 quarters · filed 2025-08-22 | $193.80M derived: sum of 3 quarters · filed 2025-08-22 | $260.49M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | $82.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $154.76M derived: sum of 2 quarters · filed 2025-08-22 | $221.45M derived: sum of 3 quarters · filed 2025-08-22 | $294.40M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | $71.79M 10-Q · filed 2024-05-06 | $138.48M derived: sum of 2 quarters · filed 2024-05-06 | $211.43M 10-Q · filed 2024-05-06 | $252.90M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | $66.69M 10-Q · filed 2024-02-07 | $139.63M 10-Q · filed 2024-02-07 | $181.10M derived: sum of 3 quarters · filed 2024-08-22 | $246.17M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $72.94M 10-Q · filed 2023-11-07 | $114.41M derived: sum of 2 quarters · filed 2024-08-22 | $179.48M derived: sum of 3 quarters · filed 2024-08-22 | $264.40M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | $41.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $106.54M derived: sum of 2 quarters · filed 2024-08-22 | $191.45M derived: sum of 3 quarters · filed 2024-08-22 | $254.14M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | $65.07M 10-Q · filed 2023-05-08 | $149.98M derived: sum of 2 quarters · filed 2023-05-08 | $212.67M 10-Q · filed 2023-05-08 | $234.37M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $84.92M 10-Q · filed 2023-02-07 | $147.60M 10-Q · filed 2023-02-07 | $169.30M derived: sum of 3 quarters · filed 2023-08-23 | $215.29M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | $62.69M 10-Q · filed 2022-11-07 | $84.38M derived: sum of 2 quarters · filed 2023-08-23 | $130.38M derived: sum of 3 quarters · filed 2023-08-23 | $195.56M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | $21.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $67.69M derived: sum of 2 quarters · filed 2023-08-23 | $132.87M derived: sum of 3 quarters · filed 2023-08-23 | $180.32M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | $46.00M 10-Q · filed 2022-05-09 | $111.17M derived: sum of 2 quarters · filed 2022-05-09 | $158.63M 10-Q · filed 2022-05-09 | $223.73M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-12-31 | $65.18M 10-Q · filed 2022-02-07 | $112.63M 10-Q · filed 2022-02-07 | $177.73M derived: sum of 3 quarters · filed 2022-08-24 | $189.06M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-09-30 | $47.45M 10-Q · filed 2021-11-08 | $112.56M derived: sum of 2 quarters · filed 2022-08-24 | $123.88M derived: sum of 3 quarters · filed 2022-08-24 | $256.78M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-06-30 | $65.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $76.43M derived: sum of 2 quarters · filed 2022-08-24 | $209.33M derived: sum of 3 quarters · filed 2022-08-24 | $215.62M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | $11.33M 10-Q · filed 2021-05-07 | $144.22M derived: sum of 2 quarters · filed 2021-05-07 | $150.51M 10-Q · filed 2021-05-07 | $163.09M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | $132.90M 10-Q · filed 2021-02-08 | $139.19M 10-Q · filed 2021-02-08 | $151.76M derived: sum of 3 quarters · filed 2021-08-25 | $199.79M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | $6.29M 10-Q · filed 2020-11-09 | $18.86M derived: sum of 2 quarters · filed 2021-08-25 | $66.90M derived: sum of 3 quarters · filed 2021-08-25 | $72.07M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-06-30 | $12.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $60.60M derived: sum of 2 quarters · filed 2021-08-25 | $65.78M derived: sum of 3 quarters · filed 2021-08-25 | $82.05M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $48.03M 10-Q · filed 2020-05-11 | $53.21M derived: sum of 2 quarters · filed 2020-05-11 | $69.47M 10-Q · filed 2020-05-11 | $82.22M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | $5.18M 10-Q · filed 2020-02-06 | $21.44M 10-Q · filed 2020-02-06 | $34.19M derived: sum of 3 quarters · filed 2020-08-26 | $94.89M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | $16.27M 10-Q · filed 2019-11-06 | $29.02M derived: sum of 2 quarters · filed 2020-08-26 | $89.71M derived: sum of 3 quarters · filed 2020-08-26 | $131.50M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $73.44M derived: sum of 2 quarters · filed 2020-08-26 | $115.23M derived: sum of 3 quarters · filed 2020-08-26 | $130.27M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | $60.69M 10-Q · filed 2019-05-07 | $102.48M derived: sum of 2 quarters · filed 2019-05-07 | $117.52M 10-Q · filed 2019-05-07 | $161.49M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | $41.79M 10-Q · filed 2019-02-07 | $56.83M 10-Q · filed 2019-02-07 | $100.80M derived: sum of 3 quarters · filed 2019-11-06 | $124.89M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | $15.04M 10-Q · filed 2018-11-07 | $59.01M derived: sum of 2 quarters · filed 2019-11-06 | $83.10M derived: sum of 3 quarters · filed 2019-11-06 | $87.28M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | $43.97M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $68.06M derived: sum of 2 quarters · filed 2019-11-06 | $72.24M derived: sum of 3 quarters · filed 2019-11-06 | $97.56M 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | $24.09M 10-Q · filed 2018-05-09 | $23.31M 10-Q · filed 2017-05-10 | $28.27M derived: sum of 2 quarters · filed 2018-05-09 | $53.59M 10-Q · filed 2018-05-09 | $49.09M 10-Q · filed 2017-05-10 | $85.28M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | $4.18M 10-Q · filed 2018-02-08 | $3.02M 10-Q · filed 2017-02-09 | $29.49M 10-Q · filed 2018-02-08 | $25.78M 10-Q · filed 2017-02-09 | $61.18M derived: sum of 3 quarters · filed 2018-08-27 | $66.52M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | $25.32M 10-Q · filed 2017-11-09 | $22.76M 10-Q · filed 2016-11-09 | $57.00M derived: sum of 2 quarters · filed 2018-08-27 | $62.34M derived: sum of 3 quarters · filed 2018-08-27 | $90.28M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | $31.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $37.02M derived: sum of 2 quarters · filed 2018-08-27 | $64.96M derived: sum of 3 quarters · filed 2018-08-27 | $64.66M 10-K · filed 2018-08-27 | |||
| 2016-03-31 | $5.34M 10-Q · filed 2017-05-10 | $33.28M derived: sum of 2 quarters · filed 2017-05-10 | $32.98M 10-Q · filed 2017-05-10 | $70.32M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | $27.94M 10-Q · filed 2017-02-09 | $27.63M 10-Q · filed 2017-02-09 | $64.98M derived: sum of 3 quarters · filed 2017-09-07 | $72.13M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | -$314.00K 10-Q · filed 2016-11-09 | $37.04M derived: sum of 2 quarters · filed 2017-09-07 | $44.19M derived: sum of 3 quarters · filed 2017-09-07 | $75.90M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | $37.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $44.50M derived: sum of 2 quarters · filed 2017-09-07 | $76.21M derived: sum of 3 quarters · filed 2017-09-07 | $82.53M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | $7.14M 10-Q · filed 2016-05-10 | $38.86M derived: sum of 2 quarters · filed 2016-05-10 | $45.17M 10-Q · filed 2016-05-10 | $70.52M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | $31.71M 10-Q · filed 2016-02-09 | $38.03M 10-Q · filed 2016-02-09 | $63.37M derived: sum of 3 quarters · filed 2016-08-29 | $101.06M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | $6.32M 10-Q · filed 2015-11-09 | $31.66M derived: sum of 2 quarters · filed 2016-08-29 | $69.35M derived: sum of 3 quarters · filed 2016-08-29 | $98.77M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | $25.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $63.03M derived: sum of 2 quarters · filed 2016-08-29 | $92.45M derived: sum of 3 quarters · filed 2016-08-29 | $91.01M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $37.69M 10-Q · filed 2015-05-11 | $67.11M derived: sum of 2 quarters · filed 2015-05-11 | $65.66M 10-Q · filed 2015-05-11 | $95.79M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | $29.42M 10-Q · filed 2015-02-09 | $27.98M 10-Q · filed 2015-02-09 | $58.10M derived: sum of 3 quarters · filed 2015-08-31 | $93.81M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | -$1.45M 10-Q · filed 2014-11-10 | $28.68M derived: sum of 2 quarters · filed 2015-08-31 | $64.39M derived: sum of 3 quarters · filed 2015-08-31 | $87.86M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | $30.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $65.83M derived: sum of 2 quarters · filed 2015-08-31 | $89.31M derived: sum of 3 quarters · filed 2015-08-31 | $105.34M 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $35.70M 10-Q · filed 2014-05-12 | $59.18M derived: sum of 2 quarters · filed 2014-05-12 | $75.21M 10-Q · filed 2014-05-12 | $117.35M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | $23.47M 10-Q · filed 2014-02-04 | $39.51M 10-Q · filed 2014-02-04 | $81.65M derived: sum of 3 quarters · filed 2014-08-29 | $141.18M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | $16.03M 10-Q · filed 2013-11-12 | $58.17M derived: sum of 2 quarters · filed 2014-08-29 | $117.71M derived: sum of 3 quarters · filed 2014-08-29 | $142.84M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | $42.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $101.68M derived: sum of 2 quarters · filed 2014-08-29 | $126.81M derived: sum of 3 quarters · filed 2014-08-29 | $150.40M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | $59.54M 10-Q · filed 2013-05-10 | $84.67M derived: sum of 2 quarters · filed 2013-05-10 | $108.26M 10-Q · filed 2013-05-10 | $136.14M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | $25.13M 10-Q · filed 2013-02-11 | $48.72M 10-Q · filed 2013-02-11 | $76.60M derived: sum of 3 quarters · filed 2013-08-29 | $110.88M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | $23.59M 10-Q · filed 2012-11-09 | $51.48M derived: sum of 2 quarters · filed 2013-08-29 | $85.75M derived: sum of 3 quarters · filed 2013-08-29 | $110.52M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $27.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $62.15M derived: sum of 2 quarters · filed 2013-08-29 | $86.93M derived: sum of 3 quarters · filed 2013-08-29 | $117.25M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $34.27M 10-Q · filed 2012-05-10 | $59.05M derived: sum of 2 quarters · filed 2012-05-10 | $89.36M 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | $24.77M 10-Q · filed 2012-02-07 | $55.09M 10-Q · filed 2012-02-07 | |||||
| 2010-09-30 | $30.32M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $96.02M 10-K · filed 2012-08-29 | ||||||
| 2009-06-30 | $85.64M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |